Loading...
Loading...
Also known as: NNC 26-0161
Selective ghrelin mimetic that triggers rapid growth hormone release without affecting cortisol or prolactin.
Benefits
6
Conditions
5
Evidence
Clinical trials, safety studies in adults+ studies
Source
Synthetic ghrelin mimetic pentapeptide
Gabriel Brain Score
Moderate
Selective ghrelin mimetic that triggers rapid growth hormone release without affecting cortisol or prolactin.
Binds ghrelin receptor (GHS-R1a) on pituitary cells, triggers rapid GH release without hypothalamic involvement, no cortisol or prolactin elevation, synergizes with CJC-1295 for optimal pulsatile GH patterns.
* Dosing should be individualized. Always consult with a qualified healthcare practitioner.
Clinical trials, safety studies in adults
Clinical evidence for selective GH release. Good safety profile with minimal side effects. Often combined with CJC-1295 for synergy.
Synthetic GHRH analog FDA-approved for reducing visceral adipose tissue in HIV-associated lipodystrophy.
Potent hexapeptide ghrelin mimetic with strong GH-releasing effects and cardioprotective properties.
Long-acting GHRH analog that stimulates sustained growth hormone release.